Trial Profile

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 26 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nogapendekin alfa inbakicept (Primary)
Indications Acute myeloid leukaemia; Bladder cancer; Breast cancer; Colorectal cancer; Fallopian tube cancer; Haematological malignancies; HIV infections; Liver cancer; Merkel cell carcinoma; Multiple myeloma; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Peritoneal cancer; Solid tumours; Squamous cell cancer
Focus Pharmacokinetics
Acronyms QUILT-1.004
Sponsors Altor BioScience Corporation

27 Feb 2025 According to an ImmunityBio media release, company to provide supportive data of lymphocyte proliferation in healthy volunteers (QUILT-1.004).
31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology
23 Aug 2019 Status changed from active, no longer recruiting to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com